The race to find a new treatment for hair loss hotted up last month with two mega funding rounds for Pelage Pharmaceuticals and Veradermics. The deals also demonstrated biopharma’s growing interest in ...

US pharma major Bristol Myers Squibb—in collaboration with Johnson & Johnson—has announced the decision to stop the Phase III ...

TandemAI has announced that it has secured a $22 million Series A extension to further develop its drug discovery platform, ...

Chinese biotech Biokin Pharmaceutical (SHA: 688506) has postponed its planned Hong Kong share listing, citing “prevailing ...

Ireland-based Avadel Pharmaceuticals today announced that it has received an unsolicited proposal from Denmark’s Lundbeck to ...

US medtech firm Terumo Blood and Cell Technologies has appointed Liza Loidolt as general manager of its cell and gene therapy ...

Merck & Co has struck a $9.2 billion deal to acquire biotechnology company Cidara Therapeutics in a move that bolsters the US ...

Neurvati Neurosciences, the neuroscience development platform of Blackstone Life Sciences, has announced the appointment of ...

UK-based life sciences venture capital firm Medicxi today announced the closing of Medicxi V, a 500 million-euros ($579.5 ...

Gate Bioscience has raised $65 million in an oversubscribed series B to advance its first molecular gate candidates, a novel ...

The pharma trade group the Association of the British Pharmaceutical Industry (ABPI) and the UK government have agreed to a ...

The US Food and Drug Administration approved USA-based Kura Oncology and Japan’s Kyowa Kirin’s ziftomenib (trade name ...